Outcome of patients hospitalized for Covid‐19 and exposure to angiotensin‐converting enzyme inhibitors and angiotensin‐receptor blockers in France: Results of the ACECoV study

Autor: Guillaume Moulis, Guillaume Martin-Blondel, Sandrine Charpentier, Agnès Sommet, Pierre Delobel, Margaux Lafaurie

Publikováno v: Fundamental & Clinical Pharmacology
Fundamental and Clinical Pharmacology
Fundamental and Clinical Pharmacology, Wiley, 2021, Fundamental & Clinical Pharmacology, 35 (1), pp.194-203. ⟨10.1111/fcp.12613⟩
Fundamental and Clinical Pharmacology, Wiley, 2021, Fundamental & Clinical Pharm acology, 35 (1), pp.192-193. ⟨10.1111/fcp.12637⟩
Fundamental & Clinical Pharmacology, 2021, Fundamental & Clinical Pharmacology, 35 (1), pp.194-203. ⟨10.1111/fcp.12613⟩

International audience; Data are lacking on the impact of ACEI/ARB exposure on unfavorable outcome in the population of patients hospitalized for COVID‐19 with hypertension/cardiovascular disease, particularly in Europe. The ACE‐CoV study was des

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b24f27b39587cffd0a47de8cd57662a